These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 20925474

  • 1. The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.
    Arnsten AF.
    Expert Rev Neurother; 2010 Oct; 10(10):1595-605. PubMed ID: 20925474
    [Abstract] [Full Text] [Related]

  • 2. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF.
    CNS Drugs; 2009 Oct; 23 Suppl 1():33-41. PubMed ID: 19621976
    [Abstract] [Full Text] [Related]

  • 3. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
    Arnsten AF, Pliszka SR.
    Pharmacol Biochem Behav; 2011 Aug; 99(2):211-6. PubMed ID: 21295057
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
    Arnsten AF, Scahill L, Findling RL.
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):393-406. PubMed ID: 17822336
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms.
    Stahl SM.
    J Clin Psychiatry; 2010 Mar; 71(3):223-4. PubMed ID: 20331927
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.
    Arnsten AF, Jin LE.
    Yale J Biol Med; 2012 Mar; 85(1):45-58. PubMed ID: 22461743
    [Abstract] [Full Text] [Related]

  • 13. Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.
    Cinnamon Bidwell L, Dew RE, Kollins SH.
    Curr Psychiatry Rep; 2010 Oct; 12(5):366-73. PubMed ID: 20652773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder.
    Arnsten AF, Steere JC, Hunt RD.
    Arch Gen Psychiatry; 1996 May; 53(5):448-55. PubMed ID: 8624188
    [Abstract] [Full Text] [Related]

  • 16. Aberrant regulation of synchronous network activity by the attention-deficit/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex.
    Zhong P, Liu W, Yan Z.
    J Physiol; 2016 Jan 01; 594(1):135-47. PubMed ID: 26541360
    [Abstract] [Full Text] [Related]

  • 17. Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic Stress.
    Hains AB, Yabe Y, Arnsten AF.
    Neurobiol Stress; 2015 Jan 01; 2():1-9. PubMed ID: 25664335
    [Abstract] [Full Text] [Related]

  • 18. Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy.
    Ota T, Yamamuro K, Okazaki K, Kishimoto T.
    Drug Des Devel Ther; 2021 Jan 01; 15():1965-1969. PubMed ID: 34007156
    [Abstract] [Full Text] [Related]

  • 19. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex.
    Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, Vijayraghavan S, Brennan A, Dudley A, Nou E, Mazer JA, McCormick DA, Arnsten AF.
    Cell; 2007 Apr 20; 129(2):397-410. PubMed ID: 17448997
    [Abstract] [Full Text] [Related]

  • 20. Neuronal basis of age-related working memory decline.
    Wang M, Gamo NJ, Yang Y, Jin LE, Wang XJ, Laubach M, Mazer JA, Lee D, Arnsten AF.
    Nature; 2011 Jul 27; 476(7359):210-3. PubMed ID: 21796118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.